Molecular imaging in experimental pulmonary fibrosis reveals that nintedanib unexpectedly modulates CCR2 immune cell infiltration
National Institutes of Health (NIH), R01HL131908 (SLB), R35HL145212 (YL), P41EB025815 (YL), K01DK133670 (DHK); Barnes Jewish Hospital Foundation (SLB).
Authors
- Sean P. Gunsten
- Kory J. Lavine (ORCID: https://orcid.org/0000-0003-1948-9945)
- Amanda R. Keller
- Hasan Farooq (ORCID: https://orcid.org/0009-0005-3782-8105)
- Hannah Luehmann (ORCID: https://orcid.org/0000-0002-7516-6772)
- Rekha M Sashti
- Deborah Sultan
- Steven L. Brody (ORCID: https://orcid.org/0000-0002-0905-7527)
- Jeffrey J. Atkinson (ORCID: https://orcid.org/0000-0001-9125-7968)
- Jeffrey R. Koenitzer (ORCID: https://orcid.org/0000-0002-4556-8455)
- Devesha H. Kulkarni (ORCID: https://orcid.org/0000-0002-8562-8205)
- Laura M. Wingler (ORCID: https://orcid.org/0000-0002-3688-5088)
- Gyu Seong Heo (ORCID: https://orcid.org/0000-0001-6200-4742)
- Yongjian Liu (ORCID: https://orcid.org/0000-0002-1118-1535)
- Tao Huang (ORCID: https://orcid.org/0000-0003-1743-1942)
Institutions
- Duke University (US)
- Washington University in St. Louis (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105431
- Citations
- 10
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Children's Discovery Institute
- Alvin J. Siteman Cancer Center
- National Institutes of Health
- Center for Cellular Imaging, Washington University
- National Cancer Institute